Other disclosuresBSE · 506197
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
01 / The disclosure
What the company shared
Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday, October 01, 2026 through Video Conferencing or Other Audio Visual Means.
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 6e41d8b4-76b8-45d0-9c3d-a2cc4144a1ec
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.